⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2442733 | 0.72 | HCAR2 (0.35) | — | |
| SCHEMBL468117 | 0.65 | — | — | |
| SCHEMBL2437914 | 0.65 | — | — | |
| SCHEMBL8848041 | 0.62 | — | — | |
| SCHEMBL8847466 | 0.61 | — | — | |
| SCHEMBL3576579 | 0.61 | — | — | |
| SCHEMBL1065269 | 0.58 | — | — | |
| SCHEMBL21379868 | 0.56 | — | — | |
| SCHEMBL745857 | 0.56 | — | — | |
| SCHEMBL9498746 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5567683-A | Substituted lactose and lactosamine derivatives as cell adhesion inhibitors | GLYCOMED INCORPORATED (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0614367-A4 | SUBSTITUTED LACTOSE AND LACTOSAMINE DERIVATIVES AS CELL ADHESION INHIBITORS. | GLYCOMED INC (US) | 1996-06-26 | — | — | EP | disclosed |
| EP-0614367-A1 | SUBSTITUTED LACTOSE AND LACTOSAMINE DERIVATIVES AS CELL ADHESION INHIBITORS | GLYCOMED INCORPORATED (US) | 1994-09-14 | — | — | EP | disclosed |
| US-5326752-A | Substituted lactose and lactosamine derivatives as cell adhesion inhibitors | GLYCOMED INCORPORATED (US) | 1994-07-05 | — | — | US | disclosed |
| WO-1993010796-A1 | SUBSTITUTED LACTOSE AND LACTOSAMINE DERIVATIVES AS CELL ADHESION INHIBITORS | GLYCOMED, INC. (US) | 1993-06-10 | — | — | WO | disclosed |